BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38193497)

  • 21. The relative propensity for regional metastasis in floor of mouth squamous cell carcinoma versus other oral cavity subsites.
    Wicks C; Zubair F; Ogunbowale A; McMahon J
    Br J Oral Maxillofac Surg; 2022 Nov; 60(9):1276-1278. PubMed ID: 36229310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Management of Operable Locally Advanced Oral Cavity Squamous Cell Carcinoma: Current Concepts and Strategies.
    Asarkar AA; Chang BA; de Bree R; Kowalski LP; Guntinas-Lichius O; Bradley PJ; de Graaf P; Strojan P; Rao KN; Mäkitie AA; López F; Rinaldo A; Palme C; Genden EM; Sanabria A; Rodrigo JP; Ferlito A
    Adv Ther; 2024 Jun; 41(6):2133-2150. PubMed ID: 38642199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical tumour margins and their significance in oral squamous cell carcinoma.
    Brennan PA; Dylgjeri F; Coletta RD; Arakeri G; Goodson AM
    J Oral Pathol Med; 2022 Apr; 51(4):311-314. PubMed ID: 35080080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck.
    Papazian MR; Chow M; Oliver J; Gordon AJ; Jacobson A; Vaezi A; Tam M; Givi B
    Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1411-1419. PubMed ID: 36892056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reply to the Letter to the Editor "'T4b' or not to 'T4b': addressing the resectability in T4b oral cavity squamous cell carcinoma".
    Thavarool SB; Narendra AK
    Int J Oral Maxillofac Surg; 2022 Dec; 51(12):1606. PubMed ID: 35534322
    [No Abstract]   [Full Text] [Related]  

  • 27. The Therapeutic Benefit of Radical Resection for T4b Oral Cavity Squamous Cell Carcinoma with Partial or Complete Response After Radical Chemo-Intensity-Modulated Radiotherapy (IMRT).
    Fang FM; Chuang HC; Chou SY; Huang TL; Wang CJ; Lin YT; Chiu TJ; Lin WC; Li SH; Su YY; Chien CY
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):866-873. PubMed ID: 27613559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of lymph node ratio for patients with mandibular infiltration of oral squamous cell carcinoma.
    Safi AF; Kauke M; Grandoch A; Nickenig HJ; Zöller J; Kreppel M
    J Craniomaxillofac Surg; 2018 Jun; 46(6):1007-1012. PubMed ID: 29709331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of recurrence amongst patients undergoing resection of oral squamous cell carcinoma with curative intent.
    Zubair F; Farooq S; Wright S; Schipani S; McMahon J
    Br J Oral Maxillofac Surg; 2022 Dec; 60(10):1379-1384. PubMed ID: 36266196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction nomogram development and validation for postoperative radiotherapy in the management of oral squamous cell carcinoma.
    Liu TPJ; David M; Clark JR; Low TH; Batstone MD
    Head Neck; 2023 Jun; 45(6):1503-1510. PubMed ID: 37019874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
    Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
    Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free three-dimensional image software in local extension assessment of oral squamous cell carcinoma: a pilot study.
    Gomes JPP; Costa ALF; Chone CT; Altemani AMAM; Altemani JMC; Lima CSP
    Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S117-S123. PubMed ID: 36030174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of dysplasia associated with oral squamous cell carcinoma in patients undergoing surgery with curative intent.
    Farooq S; Zubair F; McMahon J
    Br J Oral Maxillofac Surg; 2022 Dec; 60(10):1397-1403. PubMed ID: 36428155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of histopathological margins after resection of oral squamous cell carcinoma using sharp dissection versus mono-polar electrocautery in T1 and T2 tumors.
    Obermeier KT; Liokatis P; Smolka W
    Surg Oncol; 2023 Dec; 51():102010. PubMed ID: 37907044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical T4b Squamous Cell Carcinoma Resection With Hemimandibulectomy and Temporomandibular Joint Reconstruction With Bridging Plate and Modified Dautrey Procedure.
    Shih H; Lee JJ; Lin YT
    J Craniofac Surg; 2022 May; 33(3):e316-e318. PubMed ID: 35727658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical margins in oral squamous cell cancer: intraoperative evaluation and prognostic impact.
    Mannelli G; Comini LV; Piazza C
    Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):98-103. PubMed ID: 30844923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical coherence tomography in the assessment of oral squamous cell carcinoma resection margins.
    Hamdoon Z; Jerjes W; McKenzie G; Jay A; Hopper C
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():211-217. PubMed ID: 26210067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
    Zubair F; McMahon J; Kryklyas G; Wicks C
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment.
    Bark R; Kolev A; Elliot A; Piersiala K; Näsman A; Grybäck P; Georén SK; Wendt M; Cardell LO; Margolin G; Marklund L
    Cancer Med; 2023 Jun; 12(11):12524-12534. PubMed ID: 37084007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial.
    McCaul JA; Cymerman JA; Hislop S; McConkey C; McMahon J; Mehanna H; Shaw R; Sutton DN; Dunn J
    Trials; 2013 Sep; 14():310. PubMed ID: 24063578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.